These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 16786120

  • 1. Metronomic treatment of temozolomide inhibits tumor cell growth through reduction of angiogenesis and augmentation of apoptosis in orthotopic models of gliomas.
    Kim JT, Kim JS, Ko KW, Kong DS, Kang CM, Kim MH, Son MJ, Song HS, Shin HJ, Lee DS, Eoh W, Nam DH.
    Oncol Rep; 2006 Jul; 16(1):33-9. PubMed ID: 16786120
    [Abstract] [Full Text] [Related]

  • 2. Additive antiangiogenesis effect of ginsenoside Rg3 with low-dose metronomic temozolomide on rat glioma cells both in vivo and in vitro.
    Sun C, Yu Y, Wang L, Wu B, Xia L, Feng F, Ling Z, Wang S.
    J Exp Clin Cancer Res; 2016 Feb 13; 35():32. PubMed ID: 26872471
    [Abstract] [Full Text] [Related]

  • 3. Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model.
    Son MJ, Kim JS, Kim MH, Song HS, Kim JT, Kim H, Shin T, Jeon HJ, Lee DS, Park SY, Kim YJ, Kim JH, Nam DH.
    Int J Oncol; 2006 Jan 13; 28(1):53-9. PubMed ID: 16327979
    [Abstract] [Full Text] [Related]

  • 4. Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model.
    Banissi C, Ghiringhelli F, Chen L, Carpentier AF.
    Cancer Immunol Immunother; 2009 Oct 13; 58(10):1627-34. PubMed ID: 19221744
    [Abstract] [Full Text] [Related]

  • 5. Antiangiogenic agent, thalidomide increases the antitumor effect of single high dose irradiation (gamma knife radiosurgery) in the rat orthotopic glioma model.
    Lee JI, Itasaka S, Kim JT, Nam DH.
    Oncol Rep; 2006 May 13; 15(5):1163-8. PubMed ID: 16596180
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synergy of enediyne antibiotic lidamycin and temozolomide in suppressing glioma growth with potentiated apoptosis induction.
    Li XQ, Ouyang ZG, Zhang SH, Liu H, Shang Y, Li Y, Zhen YS.
    J Neurooncol; 2014 Aug 13; 119(1):91-100. PubMed ID: 24842385
    [Abstract] [Full Text] [Related]

  • 12. Uptake of temozolomide in a rat glioma model in the presence and absence of the angiogenesis inhibitor TNP-470.
    Devineni D, Klein-Szanto A, Gallo JM.
    Cancer Res; 1996 May 01; 56(9):1983-7. PubMed ID: 8616836
    [Abstract] [Full Text] [Related]

  • 13. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy.
    Lin CJ, Lee CC, Shih YL, Lin TY, Wang SH, Lin YF, Shih CM.
    Free Radic Biol Med; 2012 Jan 15; 52(2):377-91. PubMed ID: 22094224
    [Abstract] [Full Text] [Related]

  • 14. Trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid (anti-18F-FACBC) is a feasible alternative to 11C-methyl-L-methionine and magnetic resonance imaging for monitoring treatment response in gliomas.
    Sasajima T, Ono T, Shimada N, Doi Y, Oka S, Kanagawa M, Baden A, Mizoi K.
    Nucl Med Biol; 2013 Aug 15; 40(6):808-15. PubMed ID: 23701701
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.
    Hanihara M, Kawataki T, Oh-Oka K, Mitsuka K, Nakao A, Kinouchi H.
    J Neurosurg; 2016 Jun 15; 124(6):1594-601. PubMed ID: 26636389
    [Abstract] [Full Text] [Related]

  • 20. Local delivery of slow-releasing temozolomide microspheres inhibits intracranial xenograft glioma growth.
    Dong J, Zhou G, Tang D, Chen Y, Cui B, Dai X, Zhang J, Lan Q, Huang Q.
    J Cancer Res Clin Oncol; 2012 Dec 15; 138(12):2079-84. PubMed ID: 22825126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.